Billionaire Jim Simons' RenTech's 10 Small-Cap Stock Picks with Huge Upside Potential
Jim Simons was (and still is even after his death in May 2024) one of the biggest names – if not the biggest – in the hedge fund space.
Alkermes Plc. (ALKS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 5,738,828 | $189,496,101 | +5% | 0.29% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 4,483,285 | $148,038,071 | +8% | 1.64% |
| 3. | VenBio Select Advisor Kurt Von Emster | 2,450,000 | $80,899,000 | 1.26% | |
| 4. | Holocene Advisors Brandon Haley | 2,174,602 | $71,805,358 | +744% | 0.21% |
| 5. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,950,000 | $64,389,000 | -16% | 4.74% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.31 | 35,000 | Director | 80,000 | 2022-11-14 | Filing | |
| $23.43 | 427 | Director | 9,366 | 2022-03-04 | Filing | |
| $30.22 | 1,650 | Director | 1,650 | 2021-08-23 | Filing | |
| $26.43 | 10,000 | Director | 10,000 | 2021-08-02 | Filing | |
| $19.65 | 6,940 | Director | 11,242 | 2020-02-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.09 | 3,334 | Officer | 86,208 | 2025-06-10 | Filing | |
| $31.95 | 3,333 | Officer | 89,542 | 2025-06-09 | Filing | |
| $34.00 | 1,938 | Officer | 7,717 | 2025-02-28 | Filing | |
| $35.26 | 3,743 | Officer | 7,717 | 2025-02-25 | Filing | |
| $35.69 | 1,327 | Officer | 7,717 | 2025-02-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 27,406,368 | $904,958,288 | 0.02% | |
| 2. | 18,212,674 | $601,382,495 | 0.01% | |
| 3. | 8,022,670 | $264,908,563 | 0.01% | |
| 4. | 6,884,698 | $227,332,728 | 3.48% | |
| 5. | 5,234,995 | $172,859,555 | 0.01% |
News See All
Alkermes plc (NASDAQ:ALKS) Q1 2025 Earnings Call Transcript
Operator: Greetings, and welcome to Alkermes' First Quarter 2025 Financial Results Conference Call. My name is Maria, and I'll be the operator for today's call.
10 Best Healthcare Stocks For Long-Term Investment
In the US, healthcare expenditures and costs have been increasing. According to the Centers for Medicare & Medicaid Services, US healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.
12 Best Psychedelic Stocks to Buy in 2025
In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality." One class of hallucinogenic substances that can produce unusual states of...
Alkermes plc (NASDAQ:ALKS) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Alkermes Fourth Quarter 2024 Financial Results Conference Call. My name is Melissa, and I will be your operator for today's call.
Alkermes plc (NASDAQ:ALKS) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Alkermes' Third Quarter 2024 Financial Results Conference Call. My name is Maria and I'll be your operator for today's call.
10 Most Undervalued Quality Stocks To Buy According To Analysts
Despite global uncertainties, the US economy is viewed as stronger than its international counterparts.
Alkermes plc (NASDAQ:ALKS) Q2 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Alkermes' Second Quarter 2024 Financial Results Conference Call. My name is Rob and I'll be your operator for today's call.
Alkermes plc (NASDAQ:ALKS) Q4 2023 Earnings Call Transcript
Alkermes plc misses on earnings expectations. Reported EPS is $0.22 EPS, expectations were $0.46.
5 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising psychedelic stocks according to hedge funds.
Billionaire Hedge Funds
